Skip to main content
. 2014 Jul 28;66(8):2297–2307. doi: 10.1002/art.38672

Table 1.

Clinical characteristics of the adults with AAHS*

Total (n = 116) Underlying SLE (n = 61) Underlying AOSD (n = 31) P
Age, mean ± SD (range) years 41.6 ± 18.7 (16–86) 34.4 ± 14.2 43.4 ± 17.4 0.014
Male:female ratio 1:3 1:4.1 1:4.2
Physical findings
 Fever, no./total no. (%)§ 99/114 (86.8) 56/60 (93.3) 30/31 (96.8) NS
 Lymphadenopathy, no./total no. (%) 32/78 (41) 16/40 (40) 13/24 (54.2) NS
 Hepatomegaly, no./total no. (%) 28/67 (41.8) 12/29 (41.3) 10/20 (50) NS
 Splenomegaly, no./total no. (%) 40/88 (45.5) 15/43 (34.9) 16/25 (64) NS
Laboratory findings
 WBC count, mean ± SD (range) ×109/liter 4.1 ± 6.08 (0.1–41.1) 2.2 ± 1.2 6.8 ± 6.6 0.002
 Hgb, mean ± SD (range) gm/dl 8.9 ± 2 (4.8–14.1) 8.7 ± 1.8 9.6 ± 1.9 NS
 Platelet count, mean ± SD (range) ×109/liter 98.1 ± 96.8 (2–560) 81.9 ± 52.2 141.9 ± 142 NS
 Coagulopathy, no./total no. (%) 40/79 (50.6) 24/35 (68.6) 12/27 (44.4) NS
 AST, mean ± SD (range) IU/liter 264.2 ± 548 (9–3,420) 211.3 ± 341 423.4 ± 757.9 NS
 ALT, mean ± SD (range) IU/liter 183.6 ± 351 (6–2,126) 96.1 ± 117 315.9 ± 402 0.029
 LDH, mean ± SD (range) IU/liter 1,251 ± 1,592 (115–10,586) 1,012 ± 974 1,923.1 ± 1,721 NS
 CRP, mean ± SD (range) mg/dl 7.7 ± 10.2 (0.2–39.3) 2.8 ± 4.0 14.9 ± 12.6 0.00002
 Ferritin, mean ± SD (range) μg/liter 15,334.1 ± 35,181 (16–210,000) 5,849.5 ± 10,472 40,136.4 ± 64,069.7 0.003
*

NS = not significant; WBC = white blood cell; Hgb = hemoglobin; AST = aspartate aminotransferase; ALT = alanine aminotransferase; LDH = lactate dehydrogenase; CRP = C-reactive protein.

Includes the 61 patients with underlying systemic lupus erythematosus (SLE), the 31 with underlying adult-onset Still's disease (AOSD), and the 24 with other autoimmune diseases underlying autoimmune-associated hemophagocytic syndrome (AAHS).

Underlying SLE versus underlying AOSD.

§

Body temperature ≥37.5°C.

Hypofibrinogenemia, increased fibrinogen degradation products, or prolonged prothrombin time or activated partial thromboplastin time.